Cargando…
Risk factors associated with deep vein thrombosis in COVID‐19 patients
Autores principales: | Wang, Bin, Zhang, Li, Yin, Shanye, Deng, Wenjun, Xie, Mingxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251315/ https://www.ncbi.nlm.nih.gov/pubmed/34230922 http://dx.doi.org/10.1002/mco2.52 |
Ejemplares similares
-
Opium, an important risk factor for deep vein thrombosis patients
por: Kazemi, Toba, et al.
Publicado: (2017) -
Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients
por: Reichert, Guillaume, et al.
Publicado: (2021) -
Neurologic manifestations of nonhospitalized patients with COVID‐19 in Wuhan, China
por: Ding, Hong, et al.
Publicado: (2020) -
Azygos vein thrombosis in COVID-19
por: Chandrakar, Saurabh, et al.
Publicado: (2022) -
Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19
por: Voicu, Sebastian, et al.
Publicado: (2021)